Bourk
BioAdvisors
Embedded Files
Who We Are
Who We Are
Eliot Bourk, PhD
Founder & Principal
Over 20 years of experience across the full lifecycle of biotech and pharmaceutical innovation
Small and large biotech experience, from preclinical drug candidates to $10B+ commercial blockbusters at companies including Celgene, Gilead Sciences (Kite Pharma), Chimeric Therapeutics, and Adaptimmune
Strategy consulting background - former Managing Partner for North America at boutique strategic intelligence consultancy Deallus (now part of GlobalData)
Expert in cell therapy development and commercialization (in-house experience with 25+ cell therapy programs, 4 FDA-approved CAR-Ts)
Education:
Case Western Reserve University
BA, Biochemistry; Minor, Artificial Intelligence
UC San Diego
PhD, Molecular Pathology
Wharton School of the University of Pennsylvania
Executive Education
What We Do
Biotech BD & Commercial Strategy
Advise biotech founders and executives on strategies to create and unlock value, especially in the therapeutic areas of oncology, hematology, and immunology
Providing fractional corporate leadership in Business Development, Commercialization, Global Product & Portfolio Strategy (e.g. Chief Business Officer, VP Business Development, Head of Commercial Strategy, Global Program Leader)
Building and/or developing internal capabilities in strategy and competitive readiness
Leading and/or delivering projects in areas such as:
Business Development
Search & Evaluation
Commercial Diligence
Global Expansion Strategy
Partnership Model Evaluation
Technology Assessment
Commercial Planning & Strategy
Indication Selection
Commercial Opportunity Assessment
Disease Area Strategy
Market Landscaping
Pipeline and Portfolio Prioritization
Page updated
Report abuse